iBio, Inc. (IBIO)
| Market Cap | 272.33M |
| Revenue (ttm) | 3.00M |
| Net Income (ttm) | -27.12M |
| Shares Out | 217.85M |
| EPS (ttm) | -0.16 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 30 |
| Last Price | $1.24 |
| Previous Close | $1.25 |
| Change ($) | -0.01 |
| Change (%) | -0.80% |
| Day's Open | 1.25 |
| Day's Range | 1.23 - 1.28 |
| Day's Volume | 2,795,674 |
| 52-Week Range | 1.03 - 4.89 |
BRYAN, Texas, July 15, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that preclinical...
IBio Inc (NYSE: IBIO) has added three anti-cancer targets to its pipeline of therapeutic candidates. The Company seeks to change the drug development paradigm with the FastPharming Protein Expression S...
BRYAN, Texas, July 08, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, has taken another major step tow...
Trending penny stocks can be a great addition to your watchlist, here's 7 popular small-caps for your list The post Popular Penny Stocks to Buy Right Now? 7 For Your Watchlist appeared first on Penny St...
Are these trending penny stocks worth adding to your watchlist? The post 7 Trending Penny Stocks That You Need to Know About in July 2021 appeared first on Penny Stocks to Buy, Picks, News and Informati...
Best penny stocks to watch on Reddit with meme stocks on the rise? Check these 8 out The post 8 Reddit Penny Stocks to Watch With Meme Stocks on the Rise appeared first on Penny Stocks to Buy, Picks, Ne...
These 7 penny stocks that you may not have heard of are selling below $3 per share and are worth significantly more than their present price. The post 7 Penny Stocks to Buy if You're Looking for Hidden ...
Looking for biotech penny stocks to watch before Monday? Check these 3 out The post Best Biotech Penny Stocks to Buy?
BRYAN, Texas, June 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today the appointment ...
BRYAN, Texas, May 19, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that management wi...
BRYAN, Texas., May 17, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its financial re...
These biotech penny stocks pushed up big today; but are they worth it? The post 4 Biotech Penny Stocks That You Need to Know About appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...
BRYAN, Texas, May 10, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it will repo...
Investors are excited about the company's new coronavirus vaccine program.
Ibio (IBIO) stock is soaring higher on Friday after announcing a next-generation vaccine program to treat the novel coronavirus. The post IBIO Stock: The Covid-19 Vaccine News Sending iBio Soaring Today...
iBio, Inc. (NYSE: IBIO) shares are trading higher after the company provided an update on its IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate, I...
iBio Inc (NYSE: IBIO) has provided an update on its IBIO-201 program and reported its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of...
BRYAN, Texas, May 06, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today provided an update on its I...
A landmark legal settlement should bolster the biotech's growth prospects.
iBio Inc. (NYSE:IBIO) shares gapped higher Wednesday morning after the company announced it successfully resolved its lawsuit with Fraunhofer USA. The resolution confirms iBio's ownership of certain int...
Nemaura Medical Inc. (NASDAQ: NMRD), iBio, Inc. (NYSE: IBIO) and Cocrystal Pharma, Inc. (NASDAQ: COCP) are among the healthcare movers Wednesday. Nemaura Rallies On Receipt of Orders: Nemaura, a medtech...
Ibio (IBIO) stock is on the rise Wednesday after announcing an end to its legal battle with Fraunhofer USA and settlement agreement. The post IBIO Stock: The Big Lawsuit News That Has iBio Shares Rocket...
BRYAN, Texas, May 04, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it has succe...
Pharmaceutical stocks gained a lot from the pandemic and the race to vaccines, but most of that upside is off the table now. The post 7 Pharmaceutical Stocks That Could Get a Covid Hangover appeared fir...
Don't bet on iBio for its coronavirus vaccine candidate. It's the company's FastPharming System that could move IBIO stock in the long term.
IBIO stock is not likely to move higher given its huge dilution. I think it is not worth more than 48 cents per share.
BRYAN, Texas, March 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that it will pa...
These penny stocks are companies that have a crucial year ahead in terms of industry turnaround or company specific product development. The post 7 Penny Stocks In a Make-or-Break Year appeared first on...
With iBio making key executive-level appointments and recording excellent fiscal stats, IBIO stock's value proposition is hard to ignore. The post Hold iBio Shares as Q2 Highlights Strong Product Catalo...
iBio (NYSE: IBIO) shares are trading lower Wednesday after the company reported second-quarter earnings results. iBio's main area of business is plant-based protein expression technologies for vaccines ...
BRYAN, Tx., Feb. 16, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its financial resu...
BRYAN, Texas, Feb. 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it will rep...
Ibio (IBIO) stock is on the rise Thursday despite a lack of news coming out today that would result in the movement today. The post IBIO Stock: 5 Things for Investors to Know About iBio Today as Shares ...
If January is a sign of things to come for 2021, traders and investors are going to make a lot of money this year. 4 penny stocks on the move are Anavex Life Sciences (NASDAQ: AVXL), iBio Inc (NYSEMKT: ...
One analyst says investors are underappreciating the biotech's growth prospects.
Shares of IBIO stock are taking off on Friday after an analyst from Cantor Fitzgerald initiated an Overweight rating and $3 price target. The post IBIO Stock Alert: Analyst Call Sends Shares of Pharma i...
Innovation paid off big for investors.
BRYAN, Texas, Dec. 28, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the appointment ...
BRYAN, Texas, Dec. 10, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the closing of i...
IBIO stock remains volatile as the company continues its focus on a breakthrough product to combat the coronavirus pandemic. The post Be Wary as iBio Seeks a Place in the Vaccine Game appeared first on ...
This can happen when a company holds out its hand for a big chunk of fresh capital.
iBio (NYSE: IBIO) shares are trading lower on Tuesday after the company announced a common stock offering. iBio's main area of business is plant-based protein expression technologies for vaccines and th...
About IBIO
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and related conditions. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavir... [Read more...]
| Industry Biotechnology | |
| Stock Exchange NYSEAMERICAN | Ticker Symbol IBIO |
Financial Performance
In 2020, iBio, Inc.'s revenue was $1.64 million, a decrease of -18.83% compared to the previous year's $2.02 million. Losses were -$16.44 million, -6.56% less than in 2019.
Analyst Forecasts
According to one analyst, the rating for iBio, Inc. stock is "Strong Buy" and the 12-month stock price forecast is 2.50.